IXHL
Income statement / Annual
Last year (2024), Incannex Healthcare Limited's total revenue was $12,000.00,
and the percentage change from the previous year is not available.
In 2024, Incannex Healthcare Limited's net income was -$18.46 M.
See Incannex Healthcare Limited,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$12,000.00 |
$0.00 |
$540,170.00 |
$1.42 M |
$417,449.00 |
$1,090.28 |
$749,191.00 |
$216,774.00 |
$68,304.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$4,375.86
|
$683,839.00
|
$310,797.00
|
$0.00
|
$387,890.00
|
$396,971.00
|
$48,924.00
|
$13,759.00
|
Gross Profit |
$12,000.00
|
$0.00
|
$535,794.00
|
$739,074.00
|
$106,652.00
|
$1,090.28
|
$361,301.00
|
-$180,197.00
|
$19,380.00
|
-$13,759.00
|
Gross Profit Ratio |
1
|
0
|
0.99
|
0.52
|
0.26
|
1
|
0.48
|
-0.83
|
0.28
|
0
|
Research and Development Expenses |
$12.88 M
|
$41.66 M
|
$3.71 M
|
$3.54 M
|
$1.46 M
|
$516,807.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$16.83 M
|
$7.93 M
|
$193,985.00
|
$74,305.00
|
$315,854.00
|
$231,801.00
|
$573,429.00
|
$612,044.00
|
$268,893.00
|
$0.00
|
Selling & Marketing Expenses |
$348,000.00
|
$84,000.00
|
$1.90 M
|
$3.26 M
|
$280,348.00
|
$66,564.00
|
$901,404.00
|
$423,035.00
|
$53,447.00
|
$0.00
|
Selling, General & Administrative Expenses |
$17.17 M
|
$8.01 M
|
$4.66 M
|
$4.84 M
|
$1.35 M
|
$375,150.00
|
$2.58 M
|
$1.85 M
|
$509,604.00
|
$486,807.00
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$30.05 M
|
$49.67 M
|
$8.37 M
|
$8.40 M
|
$2.81 M
|
$891,957.00
|
$2.58 M
|
$1.85 M
|
$509,604.00
|
$486,807.00
|
Cost And Expenses |
$30.05 M
|
$49.67 M
|
$8.38 M
|
$9.09 M
|
$3.12 M
|
$891,957.00
|
$2.97 M
|
$2.24 M
|
$558,528.00
|
-$500,567.00
|
Interest Income |
$206,000.00
|
$244,013.00
|
$4,547.67
|
$1,998.39
|
$3,046.85
|
$1,114.12
|
$2,364.06
|
$6,526.57
|
$424.25
|
$3,180.83
|
Interest Expense |
$0.00
|
$3,013.00
|
$218.07
|
-$10.46
|
-$89.80
|
$60,834.00
|
$9,983.04
|
$37,558.00
|
$89.76
|
$99,835.00
|
Depreciation & Amortization |
$103,000.00
|
$23,000.00
|
$7.84 M
|
$7.64 M
|
$28,907.00
|
$29,954.00
|
$42,327.00
|
$23,270.00
|
$11,927.00
|
$13,759.00
|
EBITDA |
-$18.50 M |
-$13.62 M |
$0.00 |
$0.00 |
-$2.59 M |
-$861,461.00 |
-$2.22 M |
-$2.03 M |
-$490,224.00 |
-$2.09 M |
EBITDA Ratio |
-1542
|
0
|
0
|
0
|
-6.19
|
-790.13
|
-2.96
|
-9.35
|
-7.18
|
0
|
Operating Income Ratio |
-2503.42
|
0
|
-14.51
|
-5.39
|
-6.47
|
-817.1
|
-2.96
|
-9.35
|
-7.18
|
0
|
Total Other Income/Expenses Net |
$11.61 M
|
$857,000.00
|
-$2.45 M
|
-$863,451.00
|
-$12,418.00
|
-$110,395.28
|
-$160,173.00
|
-$14.11 M
|
-$59,592.45
|
-$1.70 M
|
Income Before Tax |
-$18.43 M
|
-$48.81 M
|
-$10.29 M
|
-$8.53 M
|
-$2.71 M
|
-$1.00 M
|
-$2.38 M
|
-$16.14 M
|
-$549,817.00
|
-$2.20 M
|
Income Before Tax Ratio |
-1535.75
|
0
|
-19.05
|
-5.99
|
-6.5
|
-918.35
|
-3.17
|
-74.44
|
-8.05
|
0
|
Income Tax Expense |
$30,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$203,999.00
|
-$229,796.00
|
$0.00
|
-$88,063.00
|
Net Income |
-$18.46 M
|
-$48.81 M
|
-$10.29 M
|
-$8.53 M
|
-$3.24 M
|
-$1.91 M
|
-$2.18 M
|
-$15.90 M
|
-$549,817.00
|
-$2.11 M
|
Net Income Ratio |
-1538.25
|
0
|
-19.05
|
-5.99
|
-7.77
|
-1750.42
|
-2.91
|
-73.36
|
-8.05
|
0
|
EPS |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
EPS Diluted |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
Weighted Average Shares Out |
$16.16 M
|
$15.38 M
|
$297.79 M
|
$244.23 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
Weighted Average Shares Out Diluted |
$16.16 M
|
$15.38 M
|
$297.79 M
|
$244.23 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
Link |
|
|
|
|
|
|
|
|
|
|